CLINICAL TRIALS PROFILE FOR ZEBETA
✉ Email this page to a colleague
All Clinical Trials for ZEBETA
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01741623 ↗ | Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fasting Condition | Completed | IPCA Laboratories Ltd. | Phase 1 | 2012-08-01 | This is a randomized, open Label, balanced, two-treatment, two-period, two-sequence, single dose, crossover pivotal study. The purpose of this study is to assess the bioequivalence between Test Product and the corresponding Reference Product under fasting condition in normal, healthy, adult human subjects. |
| NCT01744873 ↗ | Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fed Condition | Completed | IPCA Laboratories Ltd. | Phase 1 | 2012-08-01 | This is a randomized, open Label, balanced, two-treatment, two-period, two-sequence, single dose, crossover pivotal study. The purpose of this study is to assess the bioequivalence between Test Product and the corresponding Reference Product under fed condition in normal, healthy, adult human subjects. |
| NCT01955759 ↗ | Atrial Fibrillation and By-pass Surgery | Unknown status | Heart Center BH Tuzla | Early Phase 1 | 2013-12-01 | The aim of the study is to evaluate whether combined therapy with beta-blocker, amiodarone and statine is better than beta-blocker alone for the prevention of atrial fibrillation after coronary by-pass surgery. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ZEBETA
Condition Name
Clinical Trial Locations for ZEBETA
Clinical Trial Progress for ZEBETA
Clinical Trial Phase
Clinical Trial Sponsors for ZEBETA
Sponsor Name
